Characterization of a fusion protein of RGD4C and the ß-lactamase variant for antibody-directed enzyme prodrug therapy
Xiaoliang Zhou, Hao Wang, Peiji Shi, Ai-min MengInstitute of Radiation Medicine, Tianjin Key Laboratory of Molecular Nuclear Medicine, Tianjin, People's Republic of ChinaAbstract: Antibody-directed enzyme prodrug therapy (ADEPT) delivers chemotherapeutic agents in high concentration to tumo...
Main Authors: | Zhou XL, Wang H, Shi PJ, Meng AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-04-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/characterization-of-a-fusion-protein-of-rgd4c-and-the-szlig-lactamase--a16425 |
Similar Items
-
A Fusion Protein of RGD4C and β-Lactamase Has a Favorable Targeting Effect in Its Use in Antibody Directed Enzyme Prodrug Therapy
by: Hao Wang, et al.
Published: (2015-04-01) -
Antibody directed enzyme prodrug therapy : a mechanistic approach
by: Francis, Roslyn Jane
Published: (2005) -
Pharmacokinetic and pharmacodynamic challenges of Antibody-Directed Enzyme Prodrug Therapy (ADEPT)
by: Andrady, C.
Published: (2014) -
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
by: William A. Denny
Published: (2003-01-01) -
Optimized prodrug vehicles with targeting ability: the RGD4C-EcCD fusion proteins
by: Yung-Hsiang Weng, et al.
Published: (2018)